Seaflower Ventures logo

Seaflower Ventures

North America, Massachusetts, United States, Waltham

Description

A venture capital firm specializing in start up and early stage financing.

Investor Profile

Seaflower Ventures has made 12 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series A (25%)
  • Series C (25%)
  • Series Unknown (17%)
  • Series B (17%)
  • Series D (8%)
  • Private Equity (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Oncology
  • Health Diagnostics
  • Communications Infrastructure
  • Internet
  • Software
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Seaflower Ventures frequently co-invest with?

Canadian Medical Discoveries Fund
North America, Nova Scotia, Canada, Halifax
Co-Investments: 2
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 1
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Boston Millennia Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 5
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2
TL Ventures
North America, Pennsylvania, United States, Wayne
Co-Investments: 2
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 3
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 3
Mediphase Venture Partners
North America, Massachusetts, United States, Newton
Co-Investments: 4

What are some of recent deals done by Seaflower Ventures?

BridgeWave Communications

Santa Clara, California, United States

BridgeWave Communications provides outdoor gigabit wireless connectivity solutions for enterprise and service provider networks.

MobileTelecommunicationsWireless
Series CJul 30, 2007
Amount Raised: $7,800,000
Serenex

Durham, North Carolina, United States

Serenex is a drug discovery and development company focused on oncology.

BiotechnologyHealth CareMedicalOncology
Series DJun 28, 2007
Amount Raised: $26,000,000
Targanta Therapeutics

Cambridge, Massachusetts, United States

Targanta Therapeutics is a biopharma Company

BiopharmaHealth CarePharmaceutical
Series CFeb 8, 2007
Amount Raised: $70,000,000
Serenex

Durham, North Carolina, United States

Serenex is a drug discovery and development company focused on oncology.

BiotechnologyHealth CareMedicalOncology
Series COct 6, 2005
Amount Raised: $30,000,000
Sopherion Therapeutics

East Brunswick, New Jersey, United States

Sopherion has the US and Canadian rights to this liposomal nanotechnology that targets the tumor vasculature.

BiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series BSep 20, 2004
Amount Raised: $47,000,000
Serenex

Durham, North Carolina, United States

Serenex is a drug discovery and development company focused on oncology.

BiotechnologyHealth CareMedicalOncology
Series UnknownJul 30, 2004
Amount Raised: $8,000,000
Sopherion Therapeutics

East Brunswick, New Jersey, United States

Sopherion has the US and Canadian rights to this liposomal nanotechnology that targets the tumor vasculature.

BiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series AMar 10, 2003
Amount Raised: $26,000,000
Zelos Therapeutics

Conshohocken, Pennsylvania, United States

Zelos Therapeutics is a biopharmaceutical company that develops novel therapies for patients suffers from hormone-based therapeutics.

Health CareMedicalPharmaceuticalTherapeutics
Series AJan 1, 2003
Amount Raised: $11,700,000
Serenex

Durham, North Carolina, United States

Serenex is a drug discovery and development company focused on oncology.

BiotechnologyHealth CareMedicalOncology
Series BAug 20, 2002
Amount Raised: $15,000,000
PhageTech

Irvine, California, United States

PhageTech develops bio conducting materials that offers its users with advantages of immediacy, accessibility, and robustness.

Health CareMedicalMedical Device
Private EquityJan 30, 2002
Amount Raised: $10,000,000